Stock BFK PHARMESIS INTERNATIONAL LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Pharmesis International Ltd.

Equities

BFK

SG1BH6000003

Market Closed - Singapore S.E.
Other stock markets
 04:37:49 2024-04-26 am EDT 		5-day change 1st Jan Change
0.12 SGD +50.00% Intraday chart for Pharmesis International Ltd. +50.00% +22.45%
Apr. 15 Pharmesis’ Attributable Loss for 2023 Widens MT
Apr. 15 Pharmesis International Ltd. Announces the Retirement of Ms. Lin Yimin as a Director CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Pharmesis’ Attributable Loss for 2023 Widens
MT
Pharmesis International Ltd. Announces the Retirement of Ms. Lin Yimin as a Director
CI
Pharmesis Launches New Product Line
MT
Pharmesis International Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Pharmesis International Ltd. Provides Earnings Guidance for the Six Months and Full Year Ended 31 December 2023
CI
Pharmesis International Ltd. Announces Changes to the Composition of the Board and Board Committees
CI
Pharmesis International Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Pharmesis International Flags Losses for H1
MT
Pharmesis International Ltd. Provides Earnings Guidance for the Six Months Ended June 30, 2023
CI
Pharmesis International Ltd. Announces Management Resignations
CI
Pharmesis International Ltd. Appoints Lin Yimin as Non-Independent Non-Executive Director and A Member of Audit Committee
CI
Pharmesis International Ltd. Announces Temporary Work Stoppages at its Manufacturing Facilities Located in Gulin County, Luzhou City, Sichuan Province
CI
Pharmesis International Issues 4.6 Million Shares to Two Subscribers
MT
Pharmesis International Gets Regulatory Nod to List 4.6 Million Shares
MT
Pharmesis International to Issue 4.6 Million Shares to Two Subscribers
MT
Pharmesis International Expects Loss in H2, FY22
MT
Pharmesis International Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Pharmesis International's Attributable Loss Widens in H1
MT
Pharmesis International Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Pharmesis International to Post Losses in H1 Amid Lower Sales
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BFK Stock
  4. News Pharmesis International Ltd.